Global Ophthalmic Drugs Market Size, Share, and COVID-19 Impact Analysis, By Disease (Eye Allergy, Eye Infection, Glaucoma, Retinal disorders, Dry Eye, Other), By Drug Class (Anti-Allergy, Anti-Inflammatory, Antiglaucoma, Anti-VEGF Agents), By Dosage (Eye Solutions, Gels, Capsules, Eye Drops, Ointments), By Administration (Systematic, Topical Local Ocular), By Product (Prescription Drugs, Over-the-Counter-Drugs), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2021 – 2030

Industry: Healthcare

RELEASE DATE Feb 2023
REPORT ID SI1534
PAGES 199
REPORT FORMAT PathSoft

Request Sample

Your personal details will remain secure and confidential - Privacy Policy

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies